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Abstract
Background: Drynaria quercifolia L. (Family- Polypodiaceae) is a fern grows in Bangladesh used in traditional
healing by the Garo tribe of Mymensingh district. In the current study, rhizomes and fertile foliage fronds of this
plant have been investigated comprehensively to assess their in vitro membrane stabilizing, thrombolytic and
antioxidant properties.
Methods: Rhizomes and fertile foliage fronds of D. quercifolia were collected, dried, powdered and extracted with
methanol. Later on, crude methanol extracts of the plant parts were fractionated into petroleum ether, carbon
tetrachloride, chloroform and aqueous soluble fractions. The extractives were then subjected to membrane
stabilizing, thrombolytic and antioxidant assays.
Results: In membrane stabilizing assay, crude methanol extracts of rhizomes and fertile foliage fronds and their
petroleum ether fractions were found to be very effective for stabilizing erythrocyte membrane in hypotonic
solution. In case of thrombolytic study, crude methanol extract of rhizomes and its aqueous fraction exhibited
noticeable clot lysis. However, in antioxidant assays, crude methanol extracts of the tested plant parts and their
aqueous fractions exhibited potent 1,1-diphenyl-2-picrylhydrazyl (DPPH), hydrogen peroxide and 2, 2’-azinobis
(3-ethylbenzothiazoline sulphonic acid) (ABTS) radical scavenging activity. Besides, these extractives also displayed
substantial ferric reducing potential in ferric reducing antioxidant power (FRAP) assay. Crude methanol extracts of
the plant parts and their aqueous fractions were also found rich in phenolics.
Conclusion: This study demonstrates the medicinal potentials of D. quercifolia and justifies the local uses of it by
the Garo tribal people of Bangladesh for multiple disease management.
Keywords: Drynaria quercifolia, Membrane stabilizing, Thrombolytic, DPPH, Hydrogen peroxide, ABTS, FRAP,
Antioxidant, The Garo
Background
Medicinal plants are always very promising for the
development of new drugs. To distinguish any plant
possessing medicinal quality, proper scientific screening
is essential. Traditionally different plants are known to
have different efficacy for treating various types of
diseases. If the right plant is known for healing a particular
disease, attempts should be made to isolate the bioactive
lead molecule(s) from the plant [1].
Almost 30 tribal communities are living at different parts
of Bangladesh. The Garo is one of them and considered as
an ethnic group of ‘Tibbeti Borman’, belonging to the Mon-
golian human race. They are now living in Mymensingh,
Tangail, Netrokona, Sylhet and Sunamgonj districts. They
have their own curative practices involving many medicinal
plants as evident from some ethnobotanical surveys [2, 3].
These plants can be systematically evaluated to explore
their healing abilities. With this view, Drynaria quercifolia
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(L.) J. Sm., a medicinal plant used by the Garo tribe, was se-
lected to perceive its medicinal properties through chemical
and biological assays.
D. quercifolia (L.) J. Sm. (Bengali name: Bandor shoal,
Pankhiraj) belongs to a large family of ferns, Polypodiaceae,
having 56 genera and 1200 species distributed throughout
the world. It is native to Bangladesh, India, Southeast Asia,
Malaysia, Indonesia, Australia, the Philippines, New
Guinea, etc. [4]. This epiphytic or lithophytic fern is avai-
lable in wet tropical environments and generally grows on
wall, tree or rock anchored by rhizome. It has two types of
fronds known as fertile foliage fronds and sterile nest
fronds. This plant is traditionally used to heal typhoid,
hectic fever, cough, dyspepsia, jaundice, diabetes, tuber-
culosis, throat infection, etc. [5–8]. Besides, it has been
reported to have antifertility, analgesic, antiedematous,
antibacterial, etc. activities [6, 9–12]. Preliminary phyto-
chemical screening has revealed the presence of alkaloids,
glycosides, saponins, amino acids, flavonoids, triterpenes,
phytosterols and carbohydrates [11, 13].
The aim of the present study is to investigate the
rhizomes and the fertile foliage fronds of D. quercifolia
for their membrane stabilizing, thrombolytic and anti-
oxidant activities comprehensively. This might explore
the remedial potential of this plant to a great extent.
Methods
Collection and identification of plant materials
D. quercifolia is abundant in the Garo Hill of Mymensingh,
Bangladesh and was collected from there on June, 2013.
It was officially identified by an expert taxonomist at
Bangladesh National Herbarium (BNH), Mirpur Road-1,
Dhaka (http://www.bnh.gov.bd), which is a government
institute for providing plant identification service nation-
ally. An accession number DACB -38386 was provided by
BNH after identification of the submitted voucher speci-
men of the plant. The specimen has been preserved there
for future references.
Extraction
The collected rhizomes and fertile foliage fronds were
chopped, dried and powdered separately. 500 g of the each
powdered materials were soaked separately in 1.5 L of
methanol at room temperature for 7 days. The extracts
were filtered through cotton plug and concentrated with a
rotary evaporator. An aliquot (5 g) of the concentrated
methanol extract was fractionated by the modified
Kupchan method [14] into petroleum ether, carbon tetra-
chloride, chloroform and aqueous soluble fractions (Fig. 1)
followed by solvent evaporation.
Membrane stabilizing activity
This method was developed by Shinde et al. to inves-
tigate the membrane stabilizing activity of plant
extractives using erythrocytes [15]. Briefly, 5 ml of the
whole blood was collected from healthy human volun-
teers in a tube containing dipotassium salt of EDTA
(2.2 mg/ml of blood). The blood was centrifuged to col-
lect blood cells and then washed three times with iso-
tonic solution (154 mM NaCl) in 10 mM sodium
phosphate buffer (pH 7.4) through centrifugation
(10 min at 3000 g) using the same volume as super-
natant. Finally, it was resuspended in the equal volume
of this isotonic buffer solution. 0.5 ml of the suspension
was mixed with 5 ml of hypotonic solution (50 mM
NaCl) in 10 mM sodium phosphate buffered saline
(pH 7.4) containing either the extract (2 mg/ml) or ref-
erence drug, acetylsalicylic acid (0.1 mg/ml). The control
sample had 0.5 ml of erythrocytes mixed with
hypotonic-buffered saline alone. The mixture was incu-
bated for 10 min at room temperature, centrifuged for
10 min at 3000 g and the optical density (OD) of the
supernatant was measured at 540 nm by using a UV-
visible spectrophotometer. The percentage inhibition of
hemolysis was calculated using the following equation
% inhibition of hemolysis
¼ ODcontrol‐ ODtest samples
 
=ODcontrol
   100
Thrombolytic activity
The extractives were evaluated for thrombolytic activity
using human blood by a method described earlier by
Prasad et al. [16]. For this assay, 5 ml of venous blood
was collected from healthy volunteers and dispersed in
sterile pre-weighed microcentrifuge tubes (0.5 ml/tube)
followed by incubation at 37 °C for 45 min. After clot
formation, the serum was removed carefully and tubes
were weighed. 100 μl of each of the extractives (2 mg/
100 μl of water) was added in each tube. Here, 100 μl of
streptokinase (equivalent to 30,000 I.U.) (Altepase®,
Beacon Pharmaceuticals Ltd., Bangladesh) and 100 μl of
distilled water were used as positive control and negative
control, respectively. After incubation of the tubes at
37 °C for 90 min, the developed fluid from the clot was
removed and tubes were again weighed to measure the
clot lysis. Percentage of clot lysis was expressed as:
% thrombolysis
¼ weight of clot after treatment
=weight of clot before treatmentÞ  100
1,1-Diphenyl-2-picrylhydrazyl (DPPH) free radical
scavenging activity
The stable DPPH was used for the determination of free
radical scavenging activity [17]. In this assay, a methanol
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solution of the extract or standard (2 ml) at different
concentrations (500 to 15.625 μg/ml) was mixed with a
3 ml of DPPH solution (20 μg/ml methanol). Absor-
bance was determined at 517 nm by using a UV-visible
spectrophotometer after 20 min keeping in dark. The
percent inhibition was calculated from [(Ao–A1)/Ao] ×
100, where Ao is the absorbance of the control and A1 is
the absorbance of the test sample. Here, ascorbic acid
was used as standard. IC50 (half maximal inhibitory
concentration) was calculated from the graph plotted
inhibition percentage against extract concentration.
The antioxidant activity index (AAI) was calculated
from the following equation [18]:
AAI ¼ Final concentration of DPPH μg=mlÞ=IC50 μg=mlÞðð
Hydrogen peroxide free radical scavenging activity
The free radical scavenging activity of the plant extrac-
tives was also examined by using hydrogen peroxide free
radical [19]. In this experiment, 43 mM hydrogen pero-
xide solution was prepared in phosphate buffer saline
(pH 7.4). Ascorbic acid (standard) and the extract solu-
tion were arranged separately at concentration from 500
to 15.625 μg/ml. An aliquot of either standard or extract
solutions (3.4 ml) was mixed with 0.6 ml of hydrogen
peroxide solution. The reaction mixtures were incubated
at room temperature for 10 min and the absorbance was
determined at 230 nm by using a UV-visible spectropho-
tometer. The percentage inhibitory activity (I %) was
calculated from [(Ao–A1)/Ao] × 100, where Ao is the
absorbance of the control and A1 is the absorbance of
the test sample. Here, ascorbic acid was used as stan-
dard. IC50 was calculated from the graph plotted inhi-
bition percentage against extract concentration.
2, 2’-Azinobis (3-ethylbenzothiazoline sulphonic acid)
(ABTS) radical scavenging activity
ABTS scavenging activity was determined by using a
method described by Re et al. [20] with minor modifica-
tion. The stock solution was comprised of 7 mM ABTS
solution and 2.45 mM potassium persulfate (K2S2O8).
The working solution was kept at room temperature in
the dark for 16 h. The ABTS solution was adjusted with
distilled water to obtain an absorbance of 0.70 ± 0.02 at
734 nm. Fresh ABTS solution was prepared for each
assay. During test, 0.1 ml of extract or standard of differ-
ent concentrations (500-15.625 μg/ml) was allowed to
react with 2.9 ml of the ABTS solution in the dark at
room temperature for 7 min. Then the absorbance was
measured at 734 nm with the help of a UV-visible spec-
trophotometer. The percent inhibition was calculated
from [(Ao–A1)/Ao] × 100, where Ao is the absorbance of
the control and A1 is the absorbance of the test sample.
Ascorbic acid was used as standard.
Ferric reducing antioxidant power (FRAP) assay
The ferric reducing activity was conducted by a modified
method of Benzie and Strain [21]. The stock solution
was comprised of 300 mM acetate buffer (3.1 g
C2H3NaO2 · 3H2O and 16 ml C2H4O2), pH 3.6, 10 mM
2,4,6-tripyridyl-s-triazine (TPTZ) solution in 40 mM HCl
Fig. 1 Fractionation. Schematic representation of the modified Kupchan partitioning of crude methanol extracts
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and 20 mM FeCl3 · 6H2O solution. The freshly prepared
working solution was a mixture of 25 ml acetate buffer,
2.5 ml TPTZ and 2.5 ml FeCl3 · 6H2O. The temperature
of the solution was maintained at 37 °C before use. 200 μl
of extract (2.5 mg/ml) or ascorbic acid (100 μg/ml) was
allowed to react with 2800 μl of the FRAP solution for
30 min in the dark condition. The absorbance of the
colored product (ferrous tripyridyltriazine complex)
was taken at 593 nm by using a UV-visible spectro-
photometer. A standard curve was prepared for FeSO4
(0-1000 μM) and the results were expressed in μmol
of Fe+2/g dry mass.
Total phenolic content determination
Total phenolic content of the extractives was measured
by using Folin-Ciocalteu reagent as an oxidizing agent
and gallic acid as a standard [22]. In this assay, 0.5 ml of
plant extract (2 mg/ml) in water was mixed with 2.5 ml
of Folin-Ciocalteu reagent (10 times diluted with water)
and 2 ml of sodium carbonate (7.5 % w/v) solution. After
20 min of incubation at room temperature, the absor-
bance was measured at 760 nm by using a UV-visible
spectrophotometer. Total phenolic content was deter-
mined by calibration curve obtained from measuring the
known concentrations of gallic acid (0-100 μg/ml) and
expressed as mg of GAE (gallic acid equivalent)/g of the
dried extract.
Statistical analysis
Three replicates of each sample were used for statistical




The highest level of membrane stabilizing activity was
exhibited by the crude methanol extract of rhizomes
(70.9 %). The moderate membrane protecting activity
(considering >50 % inhibition of hemolysis) was noticed
by the crude methanol extract of fertile foliage fronds
and petroleum ether fractions of both the tested parts of
the plant as shown in Fig. 2.
Thrombolytic activity
The thrombolytic activity of the plant extractives is
shown in Fig. 3. Prominent thrombolysis was demon-
strated by the crude methanol extract of rhizomes
(38.34 %) and its aqueous fraction (33.32 %). Moderate
clot lysis ability (considering >25 % lysis) was seen for
the crude methanol extract and aqueous fraction of the
fertile foliage fronds. Chloroform fractions of both parts
of the fern were also moderate in thrombolysis.
DPPH free radical scavenging activity
The free radical scavenging activities are illustrated in
Fig. 4a. Crude methanol extracts of both parts of the
plant and their aqueous fractions exhibited noticeable
free radical scavenging activity with the IC50 values less
than 15 μg/ml, respectively. The antioxidant activity
index (AAI) was also calculated using both concentra-
tion of DPPH and IC50 to determine a constant for each
antioxidant and shown in the Fig. 4b. Among the tested
extractives, the aqueous fraction of the rhizome dis-
played the highest AAI (1.77), whereas crude methanol
extracts of both parts of the fern and aqueous fraction
of the fertile foliage fronds demonstrated moderate anti-
oxidant activity having AAI > 0.9.
Hydrogen peroxide free radical scavenging activity
The hydrogen peroxide free radical scavenging activities
are shown in Fig. 5. Aqueous fractions of both rhizomes
and fertile foliage fronds showed noticeable radical
scavenging activity with IC50 values 77.36 ± 2.2 and
90.33 ± 4.1 μg/ml, respectively. Besides, crude methanol
extracts displayed moderate free radical scavenging
activity having IC50 values less than 150 μg/ml.
ABTS radical scavenging activity
The ABTS radical scavenging activities of the tested
samples are presented in Fig. 6. Aqueous fraction and
crude methanol extract of rhizomes were effective scav-
engers of the ABTS radical displaying the IC50 values
23.29 ± 1.85 and 25.4 ± 2.25 μg/ml, respectively.
Ferric reducing antioxidant power (FRAP) assay
In the present study, the equation generated for the
standard curve of FeSO4 solution is as follows:
y ¼ 0:001x0:0007;R2 ¼ 0:9987
Where x is the absorbance and y is the FeSO4 equiva-
lent μmol of Fe+2/g of dried extract. Total ferric redu-
cing power of the extractives is shown in Fig. 7. The
highest reducing ability was seen for the aqueous
fraction and crude methanol extract of rhizomes having
FRAP value 42.36 ± 1.36 and 37.88 ± 1.22 μmol of Fe+2/g
of dried extract, respectively.
Total phenolic content determination
The standard curve of gallic acid provided the equation:
y ¼ 0:008x þ 0:0071; R2 ¼ 0:9986
Where x is the absorbance and y is the gallic acid
equivalent (mg/g). The phenolic content level of the
extractives is shown in Fig. 8. The highest level of phen-
olic content was determined in aqueous fractions. Crude
methanol extracts were also found rich in phenolics.
Chaity et al. BMC Complementary and Alternative Medicine  (2016) 16:184 Page 4 of 9
Discussion
The Garo is a tribal community of Bangladesh. Their
family pattern, norms, foods, festivals, etc. are differ-
ent from other tribal communities and mainstream
Bangladeshi common people [3]. The healers of this
tribe use many medicinal plants for treating their people.
Recently some ethnobotanical surveys have been con-
ducted on this [2, 6], which have revealed the studied fern,
D. quercifolia, as one of the medicinally important plants
of the Garo tribe.
Inflammation is a very complex biological state. Chronic
inflammation may be associated with aging, cancer, adipo-
genesis, diabetes, cardiovascular problems, lung disease,
etc. [23–25]. Membrane stabilization assay of erythrocytes
is a very popular tool to investigate the anitiinflammatory
potential of the plant extract. When erythrocytes are
exposed to hypotonic medium, heat, methyl salicylate,
phenylhydrazine, etc., the lysis of their membrane occurs.
It results in the leakage of serum protein and fluids into
the tissues instigating inflammation [26]. So, the com-
pounds capable of membrane stabilization might be very
suitable as antiinflammatory agents [15]. Crude methanol
extract of rhizomes demonstrated noticeable membrane
stabilizing property (Fig. 2). Moderate membrane protec-
ting activity was displayed by the crude methanol extract
of fertile foliage fronds and petroleum ether fractions of
both parts of the fern. The antiinflammatory potential of
this plant was also partially verified earlier by another
Fig. 3 Thrombolytic activity of D. quercifolia and the standard. Here, ME: crude methanol extract; PE- petroleum ether soluble fraction;
CTC- carbon tetrachloride soluble fraction; CF- chloroform soluble fraction; AQ-aqueous fraction; BLK-Blank; SK-streptokinase (standard)
Fig. 2 Membrane stabilizing activity of D. quercifolia and the standard on hypotonic solution-induced hemolysis of erythrocyte membrane. Here,
ME: crude methanol extract; PE- petroleum ether soluble fraction; CTC- carbon tetrachloride soluble fraction; CF- chloroform soluble fraction;
AQ-aqueous fraction; ASA- acetylsalicylic acid (standard)
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preliminary study using only ethanol extract of rhizomes
on mice model [9]. However, active inflammation of the
gastroduodenal mucosa is a cause of dyspepsia [27]. D.
quercifolia is well recognized to treat dyspepsia [7], which
might be linked with antiinflammatory potential of this
fern. Several flavonoids and triterpenes have been reported
earlier to have antiinflammatory activity [28, 29]. As
flavonoids and triterpenes are also present in D. quer-
cifolia [13, 30], it might be a reason for its membrane
stabilizing antiinflammatory potential.
Thrombus development leads to many vascular com-
plexities including myocardial infarction, stroke, deep
vein thrombosis, renal vein thrombosis, portal vein throm-
bosis, etc. which might result in death. Tissue plasmi-
nogen activator, urokinase, streptokinase, etc. are used
currently for treating thrombosis but better thrombolytic
agents are still a demand of time [31, 32]. In the current
study, higher thrombolytic activity was exhibited by crude
methanol extracts and aqueous fractions of both rhizomes
and fertile foliage fronds (Fig. 3). This plant was previously
Fig. 5 Hydrogen peroxide free radical scavenging assay of D. quercifolia and the standard. Here, ME: crude methanol extract; PE- petroleum ether
soluble fraction; CTC- carbon tetrachloride soluble fraction; CF- chloroform soluble fraction; AQ-aqueous fraction; ASC-ascorbic acid (standard)
Fig. 4 DPPH free radical scavenging assay of D. quercifolia and the standard representing IC50 values (a) and antioxidant activity index (b). Here,
ME: crude methanol extract; PE- petroleum ether soluble fraction; CTC- carbon tetrachloride soluble fraction; CF- chloroform soluble fraction;
AQ-aqueous fraction; ASC-ascorbic acid (standard)
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reported to have significant hypolipidemic activity on
diabetic rats [33]. The thrombolytic activity of the plant
along with lipid lowering ability might contribute to main-
tain a healthy cardiovascular system [34]. It has been
noticed earlier that flavonoids might have significant
potentials of displaying thrombolytic activity [35]. The
abundance of flavonoids in D. quercifolia might be a
reason for its thrombolytic ability [13].
Free radicals become notorious when produced in
excess in vivo and cause oxidative damages. They can
destroy immunity system and develop a wide range of
diseases such as alzheimer's disease, parkinson's disease,
complication in diabetes, rheumatoid arthritis, neuro-
degeneration, cardiovascular complications, DNA damage,
carcinogenesis, metabolic disorders, aging, etc. [36, 37].
To counteract the complications generated by free
radicals, antioxidants might be very beneficial. Different
fractions of D. quercifolia were subjected to DPPH and
hydrogen peroxide free radical scavenging assays, where
crude methanol extracts and their aqueous fractions
scavenged the free radicals evidently (Figs. 4 and 5). On
the other hand, the decolorization in ABTS assay reveals
the capacity of an antioxidant species to donate electrons
or hydrogen atoms to deactivate the radical species of
ABTS [20]. Aqueous fractions and crude methanol
extracts again displayed noticeable ABTS radical scaven-
ging capacity (Fig. 6). However, FRAP assay measures the
reducing potential, where a compound exerts its effect by
donating hydrogen atom to ferric tripyridyltriazine com-
plex and interferes the radical chain reaction [21]. In the
Fig. 7 FRAP assay of D. quercifolia and the standard. Here, ME: crude methanol extract; PE- petroleum ether soluble fraction; CTC- carbon
tetrachloride soluble fraction; CF- chloroform soluble fraction; AQ-aqueous fraction; ASC-ascorbic acid (standard)
Fig. 6 ABTS free radical scavenging assay of D. quercifolia and the standard. Here, ME: crude methanol extract; PE- petroleum ether soluble
fraction; CTC- carbon tetrachloride soluble fraction; CF- chloroform soluble fraction; AQ-aqueous fraction; ASC-ascorbic acid (standard)
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present study, aqueous fractions and crude methanol
extracts were very dominant for exhibiting ferric reducing
potentials (Fig. 7).
It is well-known that phenolic compounds are very
useful to serve as antioxidants [38]. So, the total phe-
nolic content of extractives was assessed (Fig. 8). Higher
level of phenolic content was seen in the aqueous frac-
tions and crude methanol extracts of the plant. This
finding might explain a reason for stronger antioxidant
potential of the high polar extractives.
Jaundice might cause accelerated generation of hydroxyl
radicals in plasma and liver tissues as evident from an
earlier study performed on common bile duct ligated
jaundice rats [39]. D. quercifolia is traditionally used for
curing jaundice [5] which might be related with the
antioxidant potential of this fern. A higher level of free
radicals and oxidative stress has a vital role in the deterio-
ration of diabetic complications. Therefore, use of antioxi-
dants reduces oxidative stress and helps in diabetes
management [40]. The Garo healers use D. quercifolia to
treat diabetes mellitus [6], which is very much reasonable
in the context of antioxidant potential of this fern. Anti-
oxidant treatment was reported very promising for quick
alleviation of respiratory infection and inflammation [41].
Rhizomes and fronds of D. quercifolia are also locally used
for treating tuberculosis and throat infections [8], which
might be assisted with the antioxidant potential of this
plant as evident from the present study along with its anti-
bacterial potential as reported earlier [13].
Conclusion
D. quercifolia is a medicinally important plant to the
Garo tribal people of Bangladesh. In the present study,
rhizomes and fertile foliage fronds of this fern have been
studied comprehensively. Crude methanol extracts
and petroleum ether fractions of rhizomes and fertile
foliage fronds were very promising to show membrane
stabilizing antiinflammatory potential. Besides, crude
methanol extracts and aqueous fractions were very active
for displaying thrombolytic activity. In addition, aqueous
fractions and crude methanol extracts of both parts of the
plant were very capable to scavenge the free radicals and
reduce oxidized materials, which might be attributed to
the high level of phenolic contents of the polar extractives.
The outcomes of the present study add some values to the
reported healing traits of this fern. Overall, the medicinal
potential of this plant can be considered very substantial.
Further comprehensive investigations are required to iso-
late bioactive compound(s) and know the underlying
mechanisms. Herbal drug developers might also use these
information for appropriate safety and efficacy trial in
future.
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